Preclinical biotech Synthorx wants a $100M IPO

Preclinical biotech Synthorx wants a $100M IPO

Source: 
Fierce Biotech
snippet: 

Moderna will be getting all the headlines for its monster $500 million IPO attempt this week, but that shouldn’t overshadow the major $100 million IPO that early-stage Synthorx has just announced, and what this says about the biotech market.